atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on transforming mental health disorder treatments, has announced its participation in the 2024 Maxim Healthcare Virtual Summit.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on transforming mental health disorder treatments, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The event is scheduled from October 15 – 17, 2024.
Key details of atai's involvement include:
- Participant: Srinivas Rao, M.D., Ph.D., Co-founder and Co-CEO
- Format: Virtual fireside chat
- Date: Wednesday, October 16, 2024
- Presentation Time: 3:30 P.M. EDT
A webcast registration link is provided, and an archived replay will be available on the Investors section of atai's website under Events for up to 30 days after the presentation.
Details
News Market Reaction – ATAI
The recorded move for ATAI in the trading session of this news was -0.91%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK and BERLIN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that Srinivas Rao, M.D., Ph.D., the Company’s Co-founder and Co-CEO, is scheduled to participate in the 2024 Maxim Healthcare Virtual Summit taking place from October 15 – 17, 2024. Details of the company’s participation:
Format: Virtual fireside chat
Date: Wednesday, October 16, 2024
Presentation Time: 3:30 P.M. EDT
Webcast: Register here
An archived replay will be available on the Investors section of the atai website under Events for up to 30 days.
About atai Life Sciences
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients. atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.
Contact Information
Investor Contact:
IR@atai.life
Media Contact:
PR@atai.life
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.